PIPA523453

DLL4 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA523453-Each-of-1 In Stock ₹ 44,277.50

PIPA523453 - Each of 1

₹ 44,277.50

In Stock

Quantity

1

Base Price: ₹ 44,277.50

GST (18%): ₹ 7,969.95

Total Price: ₹ 52,247.45

Antigen

DLL4

Classification

Polyclonal

Conjugate

Unconjugated

Gene

Dll4

Gene Alias

AOS6; delta 4; delta ligand 4; delta like canonical Notch ligand 4; Delta4; delta-like 4 (Drosophila); delta-like 4 homolog; delta-like 4 protein; delta-like protein 4; DLL4; Drosophila Delta homolog 4; hdelta2; MGC126344; notch ligand delta-2; notch ligand DLL4; UNQ1895/PRO4341

Host Species

Rabbit

Purification Method

Protein A

Regulatory Status

RUO

Gene ID (Entrez)

54485, 54567

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Form

Liquid

Applications

Western Blot

Concentration

0.5 mg/mL

Formulation

PBS with 0.05% BSA and 0.05% sodium azide

Gene Accession No.

Q9JI71, Q9NR61

Gene Symbols

Dll4

Immunogen

Partial synthetic peptide between amino acids 550-610 of human DLL4.

Quantity

100 μg

Primary or Secondary

Primary

Target Species

Human, Mouse

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIMA530339

--

Img

Novus Biologicals

NB399816

--

Img

Novus Biologicals

NB076213

--

Img

Thermo Scientific

PIPA523398

--

Img

Thermo Scientific

PIMA515565

--

Img

Thermo Scientific

PA549716

--

Img

Thermo Scientific

PIMA536116

--

Img

Thermo Scientific

PIMA531720

--

Description

  • Delta-like ligand 4 (DLL4), also know as Delta-4, is a homologue of the Drosophila delta protein, and functions as a transmembrane bound ligand to the notch receptor Notch1
  • DLL4 is expressed in the vasculature and plays a critical role in vascular development
  • It is induced by vascular endothelial growth factor (VEGF), as a negative feedback regulator to regulate angiogenic sprouting and promote the formulation of a differentiated vascular network
  • DLL4 has been found to be strongly expressed in tumor vessels of clear-cell renal tumors and bladder cancer, and inhibition of DLL4 results in increased vascular proliferation but defective maturation
  • This in turn leads to a decrease in tumor growth, with no apparent toxicity.